Clinic Roundup - Behavioral Health Central PDF Print
Behavioral Health CentralThe Phase Ib study is designed to assess the safety and tolerability of single ascending doses of KAI-4169 in ESRD patients with SHPT undergoing

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.